NIH to Test a Vitamin D Supplement
A clinical trial will be initiated by the U. S. National Institutes of Health (NIH) on a large scale. This was declared by NIH on Monday. The trial would examine that if a vitamin D supplement can help in preventing or delaying type2 diabetes in adults. It will be checked in case of adults who are suffering from prediabetesc and are at high risk of suffering from type 2 disorder.
The study will comprise about 2,500 people. The main aim of the study is to find out if vitamin D, particularly D3 (cholecalciferol), is capable of reducing the risk of developing type 2 diabetes in adults. The adults will be included in the study would be of 30 years or older.
People suffering from prediabetes have higher blood glucose levels as compared to normal. However, it is not high enough to be called as diabetes.
"Vitamin D use has raised sharply in the U. S. in the last 15 years, since it has been suggested as a remedy for a variety of conditions, including prevention of type 2 diabetes", said Myrlene Staten. She is Vitamin D and Type 2 Diabetes (D2d) project officer at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the NIH.
New Zealand News
- Tesla Model Y Performance becomes little bit more expensive to order in China
- Porsche’s recently unveiled Mission R Concept previews electric race cars of future
- Chinese manufacturer GAC’s Aion V e-SUV can charge 0-80% in just 8 minutes
- Oshidori International exits Japanese casino race, citing serious ethical irregularities
- CATL and LG Energy account for nearly 54% of global xEV battery market: SNE Research
- Micro Mobility shows off production version of Microlino 2.0 and 3-wheeled e-scooter
- Chinese electric motorcycle maker Evoke Motorcycles to set up shops in Spain
- TenneT adds more electric BMWs to study use of EVs to support power grids
- Italy’s ASPI announces plans to install cross-country ultra-fast EV charging network
- EV ownership costs significantly lower than conventional models: French Study